ASX - By Stock
|
PAR |
Re:
Ann: PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3
|
|
Hogana123
|
482 |
116K |
2 |
20/09/24 |
20/09/24 |
ASX - By Stock
|
482
|
116K
|
2
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
11 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
11
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
3 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3
|
|
Hogana123
|
482 |
116K |
5 |
18/09/24 |
18/09/24 |
ASX - By Stock
|
482
|
116K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
FDA delay for ph 3 trial approval
|
|
Hogana123
|
78 |
32K |
12 |
12/09/24 |
12/09/24 |
ASX - By Stock
|
78
|
32K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Chief Scientific Officer
|
|
Hogana123
|
5 |
1.7K |
1 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
5
|
1.7K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
3 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
3
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
1 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
2 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Hogana123
|
4.4K |
2.0M |
2 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Hogana123
|
4.4K |
2.0M |
11 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
11
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
5 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
5
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
2 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
2
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
1 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
1 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
8 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
1.8K
|
952K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
FDA delay for ph 3 trial approval
|
|
Hogana123
|
78 |
32K |
12 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
78
|
32K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Appendix 4E and 2024 Annual Report
|
|
Hogana123
|
33 |
15K |
5 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
33
|
15K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Appendix 4E and 2024 Annual Report
|
|
Hogana123
|
33 |
15K |
6 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
33
|
15K
|
6
|
|
ASX - By Stock
|
3DP |
Re:
report
|
|
Hogana123
|
5 |
1.7K |
3 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
5
|
1.7K
|
3
|
|
ASX - By Stock
|
3DP |
Re:
report
|
|
Hogana123
|
5 |
1.7K |
3 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
5
|
1.7K
|
3
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Preliminary Final Report
|
|
Hogana123
|
12 |
6.5K |
5 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
12
|
6.5K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
1 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
1 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
1.8K
|
952K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
0 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
7 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Mesoblast
|
|
Hogana123
|
10 |
3.9K |
1 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
10
|
3.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
10 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
10
|
|
ASX - By Stock
|
3DP |
Re:
Presentations/Webinars/Podcasts/Media
|
|
Hogana123
|
1.8K |
952K |
1 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
1.8K
|
952K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
4 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
4
|
|
ASX - By Stock
|
3DP |
Re:
3dp chart
|
|
Hogana123
|
3.7K |
1.5M |
1 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
3.7K
|
1.5M
|
1
|
|
ASX - By Stock
|
3DP |
Re:
3dp chart
|
|
Hogana123
|
3.7K |
1.5M |
4 |
17/08/24 |
17/08/24 |
ASX - By Stock
|
3.7K
|
1.5M
|
4
|
|
ASX - By Stock
|
VML |
Re:
Ann: Vital to Optimise Flowsheet in Tardiff Scoping Study
|
|
Hogana123
|
16 |
7.5K |
0 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
16
|
7.5K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
4 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
10 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
9 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
3 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
3
|
|
ASX - By Stock
|
VML |
Re:
Ann: Vital to Optimise Flowsheet in Tardiff Scoping Study
|
|
Hogana123
|
16 |
7.5K |
2 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
16
|
7.5K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Over PAR
|
|
Hogana123
|
49 |
19K |
5 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
49
|
19K
|
5
|
|
ASX - By Stock
|
VML |
Re:
Ann: Experienced Corporate Advisor Zane Lewis Joins Vital Board
|
|
Hogana123
|
8 |
3.8K |
1 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
8
|
3.8K
|
1
|
|
ASX - By Stock
|
VML |
Re:
Ann: Experienced Corporate Advisor Zane Lewis Joins Vital Board
|
|
Hogana123
|
8 |
3.8K |
0 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
8
|
3.8K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
3 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Hogana123
|
1.2K |
421K |
2 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
1.2K
|
421K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Hogana123
|
4.4K |
2.0M |
8 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
8
|
|
ASX - Day Trading
|
|
Re:
Day trading pre-market open August 12
|
|
Hogana123
|
58 |
13K |
0 |
12/08/24 |
12/08/24 |
ASX - Day Trading
|
58
|
13K
|
0
|
|
ASX - Day Trading
|
|
Re:
Day trading pre-market open August 12
|
|
Hogana123
|
58 |
13K |
1 |
12/08/24 |
12/08/24 |
ASX - Day Trading
|
58
|
13K
|
1
|
|
ASX - By Stock
|
3DP |
Re:
3dp chart
|
|
Hogana123
|
3.7K |
1.5M |
1 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
3.7K
|
1.5M
|
1
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Hogana123
|
62 |
23K |
12 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
62
|
23K
|
12
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Pointerra awarded contracts by US energy utility customer
|
|
Hogana123
|
5 |
3.3K |
11 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
5
|
3.3K
|
11
|
|
ASX - By Stock
|
3DP |
Re:
Ann: Notification regarding unquoted securities - 3DP
|
|
Hogana123
|
1 |
652 |
0 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
1
|
652
|
0
|
|